DeviceTalks Weekly Archives - Page 2 of 3

MedTech 100 roundup: Another high as stocks tick up

For the third consecutive week, stocks in the medtech industry reached heights not yet seen since the COVID-19 pandemic began.

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.65 points at the end of last week (Aug. 7). Overall, medtech stocks saw a 0.72% increase from the 89.01-point total at the same time a week prior (July 31).

On Aug. 5, the index reached 90.45 points, marking its highest point since that pre-pandemic high, with the previous mid-pandemic high (90.37) coming last week.

The most recent high mark represents just a -2% dip from the Feb. 19 high point of 92.32, marking the smallest margin of decline over the past five months.

Meanwhile, the S&P 500 Index saw a 2.5% increase from July 31 to Aug. 7, and the Dow Jones Index fared even better, positng a 3.8% rise over the same period of time.

Medtech’s lowest point during the COVID-19 pandemic remains at 62.13…

DTW Podcast: 10 ways medtech is finding its footing amid COVID-19

When COVID-19 set upon the U.S. in March, medtech executives had a month at most to tell Wall Street analysts how the pandemic had hit the industry’s largest companies. We heard about short-term hits in revenues, procedures and employee headcounts, but uncertainty clearly ruled the day.

Over the past few weeks, medtech executives from several leading companies reported back to analysts with a full quarter under their belt. To be sure, no one can claim to hold a full grasp on this crisis, but a survey of the calls reveals steps and adjustments that companies are taking to thrive beyond the pandemic.

In this podcast, we’ll list our Top 10.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

DeviceTalks by MassDevice · Ten ways medtech companies are finding their footing during the pandemic

DTW: What in the world will Thrive Earlier Detection do with $257 million?

In this week’s podcast, two executives from Thrive Earlier Detection explain how the “turbo-charged” diagnostics company intends to upend how, when and where cancer is diagnosed.

Dr. Isaac Kinde, co-founder and head of research and innovation, walks us through the company’s CancerSEEK test and how the company is marrying new technology with an innovative clinical approach. Meanwhile, CFO Isaac Ro, tells host Tom Salemi how the company closed on $257 million (hint: lots of Zoom) and why he left a career on Wall Street to join this innovative start-up.

Chris Newmarker, executive editor of life sciences at MassDevice, also counts down on the biggest newsmakers in this week’s MassDevice.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players. It’s available on Apple Podcasts, Spotify and other podcast channels.

DeviceTalks by MassDevice · What in the world will Thrive Earlier Detection do with $257 million?

DTW podcast: Connect your devices before it’s too late

Twenty years ago when he was working at the Mayo Clinic, cardiologist Dr. David Hayes shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data.

Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he said. He worried that physicians would be overwhelmed with too much data. He had other objections, too, and he’s not afraid to admit it.

“You could just check them off one-by-one,” he said in this week’s DeviceTalks Weekly podcast. “I was wrong on every one.”

Now chief medical officer for Biotronik, Hayes came around years ago and is responsible for ensuring the medical device company keeps moving forward in incorporating technology that can connect patients with physicians and hospitals. Biotronik is among the growing number of medical device companies that are examining new potential for medtech connectivity.

…

DTW podcast: Connect your devices before it’s too late

Twenty years ago when he was working at the Mayo Clinic, cardiologist Dr. David Hayes shot down the idea that medical devices would serve patients better if equipped with technology that collected and transmitted data.

Hayes had many reasons. He said patients liked coming to the doctors’ offices. “I thought they’d miss that connection,” he said. He worried that physicians would be overwhelmed with too much data. He had other objections, too, and he’s not afraid to admit it.

“You could just check them off one-by-one,” he said in this week’s DeviceTalks Weekly podcast. “I was wrong on every one.”

Now chief medical officer for Biotronik, Hayes came around years ago and is responsible for ensuring the medical device company keeps moving forward in incorporating technology that can connect patients with physicians and hospitals. Biotronik is among the growing number of medical device companies that are examining new potential for medtech connectivity.…

CVRx CEO Yared on selling during a pandemic and improving diversity, equality inside and outside of medtech

Nadim Yared, CEO of CVRx

In part 2 of an interview, we follow up with last week’s guest, CVRx CEO Nadim Yared, to catch up on how the medtech executive is managing during the pandemic.

Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society.

We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups. Hyalex was identified as a notable startup in this recent report in Medical Design and Outsourcing.

In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks by MassDevice · CVRx Nadim Yared on COVID-19, diversity and …

CVRx CEO Nadim Yared suggests steps toward improving diversity and equality

Nadim Yared, CEO of CVRx

In this week’s episode of DeviceTalks Weekly, we follow up with last week’s guest, Nadim Yared, CEO of CVRx, to catch up on how the medtech executive is managing during the pandemic.

Yared also shares some far-reaching views on what the medtech industry needs to work toward to improve diversity in its workforce and provide equality for society.

We also visit with Mira Sahney, CEO of Hyalex Orthopaedics, one of medtech’s most interesting startups. Hyalex was identified as a notable startup in the recent report in Medical Design and Outsourcing. In this interview, Sahney reveals Hyalex’ origins, the state of its potential cartilage replacement product, and why start-ups have a natural advantage operating in a pandemic.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

DeviceTalks by MassDevice · CVRx Nadim Yared on COVID-19, diver…

MedTech 100 roundup: Stocks tick back up to open July

After a solid start to July, the medtech industry continues to experience a stock market roller coaster amid the COVID-19 pandemic.

MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 84.25 points at the end of last week (July 3). That total represents a 2.9% increase from the 81.88-point total at the same time a week prior (June 26), resulting in another significant direction change, following a -3.7% dip just one week before.

Meanwhile, the S&P 500 Index saw a 4% bump from June 26 to July 2 (market close before a holiday), and the Dow Jones Index fared similarly well, posting a 3.2% increase over the same period of time. Both indexes mirrored the medtech industry’s changes, having each posted decreases the week prior.

Medtech’s lowest point during the COVID-19 pandemic remains at 62.13 on March 23. Since then, the industry’s stocks have experienced 35.6% growth in total. Stocks in the indu…

Mayo Clinic needed to engineer its way through COVID-19: Here’s what they did.

The health system’s medical and engineering staffs had to devise their own solutions for lab gear, PPE and operating room air decontamination.

[Image courtesy of Mayo Clinic]

As COVID-19 settles into several regions of the U.S., healthcare systems that once sat on the sidelines likely will find themselves in the same situation as their counterparts in the Northeast did earlier this year.

While this may serve as little comfort, hospitals in regions getting hit by the new wave of the deadly virus do have the benefit of seeing how hospitals in the Upper Midwest and the Northeast managed the pandemic.

One of the easiest — or at least most evident — lessons available is the use of additive manufacturing or 3D printing. Mayo Clinic and other hospital systems, including Beth Israel Lahey in Boston, used their 3D printers to produce critical personal protective equipment (PPE) such as masks and face shield…

Mayo Clinic needed to engineer its way through COVID-19: Here’s what they did.

The health system’s medical and engineering staffs had to devise their own solutions for lab gear, PPE and operating room air decontamination.

[Image courtesy of Mayo Clinic]

As COVID-19 settles into several regions of the U.S., healthcare systems that once sat on the sidelines likely will find themselves in the same situation as their counterparts in the Northeast did earlier this year.

While this may serve as little comfort, hospitals in regions getting hit by the new wave of the deadly virus do have the benefit of seeing how hospitals in the Upper Midwest and the Northeast managed the pandemic.

One of the easiest — or at least most evident — lessons available is the use of additive manufacturing or 3D printing. Mayo Clinic and other hospital systems, including Beth Israel Lahey in Boston, used their 3D printers to produce critical personal protective equipment (PPE) such as masks and face shiel…

Mayo Clinic needed to engineer its way through COVID-19: Here’s what they did.

The health system’s medical and engineering staffs had to devise their own solutions for lab gear, PPE and operating room air decontamination.

[Image courtesy of Mayo Clinic]

As COVID-19 settles into several regions of the U.S., healthcare systems that once sat on the sidelines likely will find themselves in the same situation as their counterparts in the Northeast did earlier this year.

While this may serve as little comfort, hospitals in regions getting hit by the new wave of the deadly virus do have the benefit of seeing how hospitals in the Upper Midwest and the Northeast managed the pandemic.

One of the easiest — or at least most evident — lessons available is the use of additive manufacturing or 3D printing. Mayo Clinic and other hospital systems, including Beth Israel Lahey in Boston, used their 3D printers to produce critical personal protective equipment (PPE) such as masks and face shiel…

Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

In this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by startups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function.

Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, senior program manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Register for the free discussion…